NPI: 1295842615 · LONG ISLAND CITY, NY 11101 · Pharmacy · NPI assigned 08/23/2006
Authorized official BURR, KEVIN controls 20+ related entities in our dataset. Read more
| Authorized Official | BURR, KEVIN (SECRETARY) |
| NPI Enumeration Date | 08/23/2006 |
Other providers sharing the same authorized official: BURR, KEVIN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,526 | $4.55M |
| 2019 | 2,747 | $5.09M |
| 2020 | 2,264 | $4.69M |
| 2021 | 2,034 | $4.57M |
| 2022 | 1,492 | $4.23M |
| 2023 | 748 | $1.61M |
| 2024 | 410 | $582K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J2323 | Injection, natalizumab, 1 mg | 1,658 | 1,540 | $11.38M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 5,781 | 5,687 | $7.18M |
| J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | 1,101 | 986 | $3.16M |
| J0897 | Injection, denosumab, 1 mg | 1,003 | 980 | $1.29M |
| J2315 | Injection, naltrexone, depot form, 1 mg | 521 | 499 | $699K |
| J0517 | Injection, benralizumab, 1 mg | 87 | 81 | $416K |
| Q9991 | Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg | 203 | 190 | $320K |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 95 | 95 | $259K |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 185 | 168 | $239K |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 88 | 88 | $141K |
| J1729 | Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg | 41 | 40 | $89K |
| J3590 | Unclassified biologics | 12 | 12 | $87K |
| J2182 | Injection, mepolizumab, 1 mg | 21 | 13 | $40K |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 223 | 223 | $23K |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 460 | 359 | $0.00 |
| J7517 | Mycophenolate mofetil, oral, 250 mg | 38 | 38 | $0.00 |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 305 | 289 | $0.00 |
| J7518 | Mycophenolic acid, oral, 180 mg | 124 | 108 | $0.00 |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 275 | 245 | $0.00 |